Rational Engineering of TIL with Membrane-Bound IL15 to Optimize Expansion, Persistence, Safety, & Efficacy of TIL Cell Therapy for Solid Tumors
Time: 4:00 pm
day: Conference Day One
Details:
- Evaluating the design of T-cells to utilize IL15
- Key advantages of membrane bound IL15 over IL2
- Clinical data on effects of IL15 and its safety characterization
